Metabolic Disease Drug Development Tools
Metabolic disorders (MDs) are a group of complex diseases caused by defects in enzymes or proteins within metabolic pathways, typically resulting from genetic factors, environmental influences, or a combination of both. These disorders often involve abnormalities in carbohydrate metabolism, lipid metabolism, amino acid metabolism, mineral, and bone metabolism, ultimately disrupting normal physiological functions in the body.
ACROBiosystems is committed to providing comprehensive drug development tools for the biopharmaceutical industry. To support metabolic disease drug discovery, ACROBiosystems has developed a complete portfolio of high-quality Recombinant Proteins, Antibodies, Cell Lines, and Assay Kits, along with integrated One-Stop Services. Our solutions are designed to accelerate every stage of metabolic disease biologics development—empowering your research from target validation to clinical translation.
| Discovery & Development | Manufacturing & Quality Control | Preclinical & Clinical Studies |
|---|---|---|
|
Target Proteins 100+ relafed targets covered Functional Cell Lines TR-FRET Kits Inhibitor Screening Kits Molecular Interaction Analysis Services (SPR & BLI) ... |
GMP-grade Reagents Recombinant Factor C Endotoxin Detection Kit Residual Detection Kits ... |
Organoid-related Solutions Anti-Idiotypic Antibody Development Service Cytokine Detection ELISA Kits ... |
ACROBiosystems' comprehensive drug development solutions
Glucose Metabolism Disorders
Lipid Metabolism Disorders
Amino Acid Metabolism Disorders
Mineral and bone metabolism disorders
Featured Recommendations
Related Resources
Brochure Download
References
-
1. Haythorne, E., Rohm, M., van de Bunt, M. et al. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells. Nat Commun 10, 2474 (2019). https://doi.org/10.1038/s41467-019-10189-x
-
2. Badimon, Lina & Chiva-Blanch, Gemma. (2019). Lipid Metabolism in Dyslipidemia and Familial Hypercholesterolemia. 10.1016/B978-0-12-811297-7.00024-X.
-
3. Wang Z, Wu X, Chen HN, Wang K. Amino acid metabolic reprogramming in tumor metastatic colonization. Front Oncol. 2023 Mar 14;13:1123192. doi: 10.3389/fonc.2023.1123192. PMID: 36998464; PMCID: PMC10043324.
-
4. Montaner Ramón A. Risk factors of bone mineral metabolic disorders. Semin Fetal Neonatal Med. 2020 Feb;25(1):101068. doi: 10.1016/j.siny.2019.101068. Epub 2019 Dec 2. PMID: 31862224.
- Background
- Glucose Metabolism Disorders
- Lipid Metabolism Disorders
- Amino Acid Metabolism Disorders
- Mineral and bone metabolism disorders
- Featured Recommendations
- Related Resources
- References